Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00306254 · ClinicalTrials.gov registry record · Phase 2
Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,225
- Enrollment target
NCT00306254: Completed Phase 2 study, sponsored by Pfizer.
NCT00306254 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 1,225 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (821% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00306254, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,225 participants
- Enrollment target
Study Summary
To study the safety and effectiveness of several doses of PD 0348292 compared to enoxaparin in preventing blood clots in the lungs or deep leg veins of patients after knee surgery
Interventions
- DRUG Enoxaparin
- DRUG PD 0348292
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,225 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
What the finished NCT00306254 record still lists
NCT00306254 is an interventional study that assigns participants to a tested intervention. Its 1,225 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (821% higher).
The record links to 0 conditions, and to 2 interventions - of which Enoxaparin is the first listed.
NCT00306254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00306254 about?
NCT00306254 is a clinical study titled "Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery". To study the safety and effectiveness of several doses of PD 0348292 compared to enoxaparin in preventing blood clots in the lungs or deep leg veins of patients after knee surgery
What is the current status of trial NCT00306254?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,225 participants. The study started on 2006-03. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00306254?
The interventions under investigation include: Enoxaparin (DRUG), PD 0348292 (DRUG).
Who is sponsoring clinical trial NCT00306254?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00306254's enrollment target sits among peer trials
1,225 16th of 2000 higher than 1,985 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- NCT05456841 · 1,232 participants · NA
Empathic Communication Skills (ECS) Training
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia